Gambro Sells U.S. Kidney Clinics Unit  STOCKHOLM (Reuters) - Swedish kidney-care company Gambro AB  has signed an agreement to sell its U.S. clinics business to  dialysis firm DaVita Inc. for \$3.05 billion in cash, Gambro  said on Tuesday.